CareersInvestor RelationsPress RoomCOVID-19
  • Contact
  • Products & Services
  • Clinical Specialties
  • About us
  1. Home
  2. Laboratory Diagnostics
  3. Plasma Proteins
  4. Plasma Protein - Webinars
  5. BTP in secretions as a valuable marker for detection of CSF leakage syndromes

BTP in secretions as a valuable marker for detection of CSF leakage syndromes

Prof. Dr. A. Huber
Aarau, Switzerland
|2014-05-09
Click to play video

Related Products, Services & Resources

A personalized cancer therapy can only be generated with enough data. The bioinformatics analysis submits data fast and efficiently.

Comprehensive Molecular Profiling for Targeted Cancer Therapy

Markus Tiemann, MD, discussed molecular pathology, clinical decision-making in oncology, and his recent collaboration with the Siemens’ daughter NEO New Oncology in the field of molecular tumor diagnostics.

The proof: True Breast Tomosynthesis increases breast cancer detection rate by 43%<br />

The proof: True Breast Tomosynthesis increases breast cancer detection rate by 43%

Malmö Study reveals: True Breast Tomosynthesis from Siemens increases breast cancer detection rate by 43%.

Contact Us
Services & SupportEducation & Training
Share this page:

  • Siemens Ltd Saudi Arabia ©2021Corporate InformationPrivacy PolicyTerms of UseCookie Policy